DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the KMC Speciality Hospitals (India) Ltd (KMCSHIL) share price today?

KMC Speciality Hospitals (India) Ltd (KMCSHIL) is trading at ₹133.4 on the BSE, down 0.26% on the day. Source: DocStoX.

What is the PE ratio of KMC Speciality Hospitals (India) Ltd?

KMC Speciality Hospitals (India) Ltd has a price-to-earnings (PE) ratio of 101.8 in the Healthcare sector.

What is the market capitalisation of KMC Speciality Hospitals (India) Ltd?

KMC Speciality Hospitals (India) Ltd has a market capitalisation of approximately ₹2,208 crore.

KMC Speciality Hospitals (India) Ltd

KMCSHIL·BSE·Healthcare

₹133.40▼ -0.35 (-0.26%)

Healthcare · Healthcare Services

A steady, established business

Day₹132.50

₹136.00

52W₹63

₹14685%

Open

₹133.10

High

₹136.00

Low

₹132.50

Prev Close

₹133.75

Volume

78.6K

VWAP

₹133.76

Snapshot

Key fundamentals

Market Cap

₹2,208 Cr

P/E Ratio

101.83Expensive

P/B Ratio

10.37

EPS

₹1.31

Book Value

₹12.90

ROE

13.04%Average

ROCE

17.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.40Moderate

Face Value

₹1.00

52W High

₹145.90

52W Low

₹62.50

Sector

Healthcare

Industry

Healthcare Services

Avoid

None moatHigh uncertainty

Fair value estimate

₹15

▼ 88.6%downside

Trading at ₹133 — 89% above our estimate

BearFair valueBull

₹13₹15₹23

/100

Business quality — Watch the fundamentals

Growth 50Profitability 40Efficiency 45Valuation 40

Plain English

Our view

A steady, established business
Low debt relative to equity
Expensive — trades at 102× earnings

Strengths

Low debt relative to equity
Promoters hold a controlling stake

Risks

Expensive — trades at 102× earnings

How we got there

Fair value methods

Residual income

13% ROE fading to 13% over ~3 yrs, on ₹13 book

₹13

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹23

Analyst target

No analyst coverage

—

Blended fair value₹15

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Promoters hold a controlling stake

Bear case

Expensive — trades at 102× earnings

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

101.8Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

13.0%Average

Above 15% is considered healthy for Indian equities

ROCE

17.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.40Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹2,208 Cr

P/B

10.37

EPS

₹1.31

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Expensive

P/E 101.8×

Growth

Strong

+25% rev CAGR

Profitability

Healthy

13.0% ROE

Financial health

Comfortable

D/E 0.40

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹105.15L Cr

Trades1,103

VWAP₹133.76

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+25.1%

+24.3%

10Y

+21.7%

Profit

+20.4%

+29.4%

10Y

+31.7%

EPS

+2.6%

+17.8%

10Y

+24.4%

Profile

Pros

Company is expected to give good quarter
Company has delivered good profit growth of 29.6% CAGR over last 5 years
Company's median sales growth is 22.9% of last 10 years

Watch-outs

Cons

Stock is trading at 10.4 times its book value
Though the company is reporting repeated profits, it is not paying out dividend

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

75%

Promoter

Promoters

75.0%0.00

Public

22.0%-0.01

FII / FPI

0.0%+0.02

DII

0.0%0.00

Others

3.0%

Total shareholders

88,487+2,169 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter75.00%

FII0.02%

Public22.01%

Others2.97%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions